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A B S T R A C T
This paper describes the epidemiological and clinical features of a tick-borne disease differing somewhat
from other tick-borne diseases found previously in Spain. All patients were bitten by Dermacentor
marginatus or a large tick. The clinical features include a crustaceous or necrotic lesion at the site of the
tick’s attachment, surrounded by an erythema (erythema migrans-like) and painful regional lympha-
denopathies. The probable aetiological agent is Rickettsia slovaca. Similar cases have been reported in
other European countries.
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I N T R O D U C T I O N
Hard ticks are haematophagous arthropods that
feed on different mammals, birds and reptiles. They
can transmit a broad variety of infectious and toxic
diseases, but humans are only occasional hosts.
Tick-borne diseases (TBDs) result from at least
three elements: the geographical presence of each
tick species, the presence of a transmissible agent,
and a susceptible host [1,2]. This paper describes
22 patients with a TBD not described previously in
Spain. Raoult et al. [3] and Lakos [4] have described
cases with similar characteristics in other countries,
and have implicated Rickettsia slovaca as the aetio-
logical agent. The vector is Dermacentor marginatus.
A preliminary description of this new TBD in Spain
has been published elsewhere [5].
P A T I E N T S A N D M E T H O D S
Study site
All patients were living in La Rioja, a region of Northern Spain,
and were diagnosed in Hospital de La Rioja, Logran^o, which is
the regional reference centre for zoonoses (including TBD) and
serves an area with > 260 000 inhabitants. The region has
different ecological habitats, some of which (e.g., mountains)
are favourable for Lyme borreliosis and human granulocytic
ehrlichiosis (HGE) [6], while others (e.g., valleys) favour
Mediterranean spotted fever [7]. The study was prospective
(January 1999 to April 2001) for seven patients and retrospec-
tive (January 1990 to December 1998) for 15 patients.
Patients
Criteria for inclusion
1. Patients bitten by Dermacentor spp. or a large tick during the
period of maximum activity for D. marginatus (in our area,
October to April) were included. Patients bitten by Ixodes
ricinus, or Rhipicephalus sanguineus, or those who had been
bitten in a period of maximum activity of these ticks (from
the beginning of May to the end of September) were
excluded.
2. All included patients had a crustaceous eruption or a
point of necrosis (eschar) at the tick’s attachment site,
surrounded by erythematous skin and regional lympha-
denopathy.
3. Included patients had negative serological tests (acute
and convalescent sera) for Borrelia burgdorferi (B. burgdorferi
Virotech ELISA IgG and IgM; Genzyme, Neu-Isenberg,
Germany), Francisella tularensis (F. tularensis antigen tube
test; Difco, Detroit, MI, USA), and HGE (HGE immunoflu-
orescence assay for IgG; MRL Diagnostics, Cincinatti, OH,
USA). The presence of antibodies against Rickettsia conorii
(R. conorii IFI assay; BioMe´rieux, Lyon, France) was not
considered to be a reason for exclusion, because there is a
serological cross-reaction between the two Rickettsia spp. [8].
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The following additional microbiological studies (not
necessary for inclusion) were performed for some patients,
all of whom matched the above criteria.
Determination of antibodies against R. slovaca
Immunofluorescent assays were performed in the Unite´ des
Rickettsies, Marseille, France, and in the Centre of Estudos
de Vectores e Doenas Infecciosas, Aguas de Moura, Portugal.
Skin biopsy
In three patients, a skin biopsy (punch and ⁄ or conventional
biopsy) was performed to investigate the presence of spotted
fever group rickettsias by PCR (amplification with citrate
synthase primers) as described by Roux et al. [9]. The
possible presence of B. burgdorferi was also investigated by
means of culture (BSK medium) and PCR, as described
previously [10].
Tick study
A specimen of D. marginatus, collected from a patient with the
typical clinical picture in 1996, was investigated by PCR
(citrate synthase gene) for Rickettsia spp. [9]. The possible
presence of B. burgdorferi was also investigated by means of
culture (BSK medium) and PCR, as described previously [10].
R E S U L T S
Epidemiological data
Twenty-two (13.2%) of 167 patients with TBD
diagnosed during the study were included. The
main epidemiological and clinical characteristics
of the patients are shown in Table 1. The average
age was 37.5 years (range: 3–67 years), with
45.5% male and 54.5% female patients. The
monthly distribution of the tick bites is shown
in Fig. 1. All tick bites occurred during the colder
months, with a peak in November. In 11 (50%)
cases, D. marginatus was identified or recognised
by the patients from a tick image collection. In the
remaining cases, a large engorging tick bite was
reported.
Clinical data
The main signs and symptoms present in all the
patients were a crustaceous lesion (early) or eschar
(late) at the site of the tick’s attachment (Fig. 2)
and regional painful lymph nodes. Surrounding
erythema was present in all patients, and this
was ‡ 5 cm in diameter (erythema migrans-like)
in 36.6% of patients (Fig. 3). One patient had
an erythema that was > 40 cm in diameter. All
eschars were located on the upper portion of the
body, usually on the occipital scalp (86.4%). Low-
grade fever (< 38 C) was present in 45.5% of
patients. All but one patient with eschar in the
scalp suffered from headache. The mean incuba-
tion period after the tick bite was 4.2 days (range:
1–8 days). No other skin lesions were detected.
Routine laboratory tests were normal in
17 patients, but five (22.7%) had raised alanine
aminotransferase and aspartate aminotransferase
levels (less than twice the upper limit of normal
levels). All patients, with the exception of a child
who received josamycin, were treated with oral
Table 1. Epidemiological and clinical characteristics of the patients







nodes Fever Headache Transaminases
1 60 F April Viguera Head UN 5 Yesa Yes Yes Yes Elevated
2 51 M January Arnedo Head DM 7 Yes Yes Yes Yes Elevated
3 59 F November Arnedo Arm DM 6 Yesa Yes No No Normal range
4 26 F March Arnedo Head DM 4 Yes Yes No No Normal range
5 11 F November UN Head DM 4 Yes Yes No Yes Normal range
6 28 F December UN Head UN 7 Yes Yes Yes Yes Normal range
7 44 F February UN Head UN 5 Yes Yes No Yes Normal range
8 7 M October UN Head UN 5 Yes Yes Yes Yes Normal range
9 3 F October UN Head DM 3 Yes Yes No Yes Normal range
10 39 F November Logron˜o Head UN 4 Yes Yes Yes Yes Normal range
11 29 M November Sotes Head DM 3 Yes Yes Yes Yes Elevated
12 31 F December Pre´jano Head DM 4 Yes Yes Yes Yes Normal range
13 44 F January M. de Oco´n Head UN 3 Yesa Yes No Yes Normal range
14 66 F October Arnedo Head DM 6 Yes Yes No Yes Normal range
15 21 M December Arnedillo Head UN 4 Yes Yes Yes Yes Normal range
16 67 M November Arnedo Chest DM 8 Yesa Yes No No Normal range
17 49 F March Arnedo Head UN 5 Yesa Yes Yes Yes Elevated
18 22 M March Aldeanueva Head DM 4 Yesa Yes No Yes Normal range
19 45 M April Tudelilla Axilla DM 8 Yesa Yes No No Normal range
20 49 M April V. de Oco´n Head UN 1 Yes Yes Yes Yes Normal range
21 25 M January UN Head UN 3 Yes Yes No Yes Normal range
22 48 M January Sta. Engracia Head UN 1 Yesa Yes No Yes Elevated
DM, Dermacentor marginatus; F, Female; M, Male; NP, not performed; UN, unknown.
aErythema > 5 cm in diameter.
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doxycycline (100 mg twice-daily for 14 days). The
resolution of lymphadenopathies in a few days
was the rule, but the eschar had a torpid evolution
that resulted in alopecia lasting for several
months. None of the patients were hospitalised,
and all had a favourable resolution.
Serological and microbiological findings
Serological assays for R. slovaca were performed for
12 (55.5%) patients; seven of these were prospect-
ive, and stored sera were available for five of them.
A low titre, with a previous negative result, was
observed for only three patients. These three
patients also had a serological response against
R. conorii. Antibody titres against R. slovaca and
R. conorii were similar (Table 2).
The results of all microbiological investigations
(culture in BSK medium, PCR for B. burgdorferi,
and PCR for Rickettsia spp.) were negative in the
three patients where skin biopsies were analysed.
For case 16 (Table 2), it was possible to investi-
gate the tick (an adult engorged female D. margin-
atus) by PCR. The results were positive for Rickettsia
spp., and subsequent sequencing indicated that
the species involved was R. slovaca (unpublished
results).
D I S C U S S I O N
Different TBDs have now been described, both in
Europe and worldwide [1,11]. Lyme borreliosis
and Mediterranean spotted fever are the most
prevalent TBDs in Spain [2,12], but other TBDs,
such as HGE [13], tick paralysis [14], babesiosis
and tularemia [15] have been described.
This paper presents data about a new TBD in
Spain. The vector is D. marginatus, and the clinical
picture is different from the other TBDs described
in the area. A point of necrosis (eschar) at the site
of the tick’s attachment, surrounded by an erythe-
matous skin lesion and regional lymphadenopa-
thy, are the most prominent signs of this disease.
The epidemiological data are also different from
those of the other TBDs, since the tick bite occurs
during the colder months of the year.
Although there are clinical and epidemiological
differences compared to the other TBDs described
in Spain, there is a great similarity to the patients
described in France and Hungary by Raoult et al.
[3] and Lakos [4], respectively. The disease









































Fig. 1. Distribution of cases by months.
Fig. 2. Detail of the eschar on the scalp.
Fig. 3. Eschar (tache-noire-like) at the point of the tick’s
attachment, surrounded by erythema migrans-like lesion.
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borreliosis, Mediterranean spotted fever or ehrli-
chiosis. The clinical picture partly resembles
Lyme borreliosis (erythema migrans-like lesion)
and Mediterranean spotted fever (tache noire-like
lesion at the tick’s attachment site), but the site of
the tick bite differs, being located mostly on the
scalp (86.4% of patients) and always on the upper
portions of the body. As with early localised
Lyme borreliosis, but in contrast to spotted fever,
the systemic signs and symptoms are not prom-
inent. The only symptoms are headache (95%
when the tick attachment is on the scalp) and the
development of an enlarged painful regional
lymphadenopathy. Only 45.5% of patients had
low-grade fever, and even fewer cases (22.7%)
had elevated liver enzymes.
The disease vector, D. marginatus, is a hard tick
(Ixodidae), present in all parts of Europe, that
feeds on a variety of different mammals. In Spain,
it feeds mainly on wild boars (Sus scrofa) during its
adult stage. Our microbiological data are not
sufficient to definitively confirm R. slovaca as the
aetiological agent of this TBD. A poor and late
serological response against this organism was
observed in 25% of patients analysed. Similar
findings were reported by Raoult et al. [16]. All
patients with antibodies against R. slovaca also
showed low titres of antibodies against R. conorii
because of cross-reaction (both of these organisms
are included in the same group of rickettsiae) with
immunofluorescence assays [8]. However, the
assay for R. conorii is currently the best serological
marker that is widely available for this infection,
since 45.5% of patients had antibodies against
R. conorii (an assay for R. slovaca is currently
only available in specialist reference laboratories).
R. slovaca was found in an engorged female
D. marginatus tick attached to a patient with the
typical clinical picture. R. slovaca was also detected
in the border of the lesion (skin biopsy) and in one
tick after PCR and sequencing in the first case
report described by Raoult et al. [3]. Lakos [17]
found the same species by PCR in Hungarian
patients. Overall, the data presented in the present
study indicate that clinicians should be aware that
this tick-related disorder can be found in Spain as
well as in other parts of Europe.
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A D D E N D U M
Since the preparation of this paper, we have analysed DNA
from six D. marginatus ticks collected from patients and 38 from
wild boars by a semi-nested PCR (ompA gene) with the primers
described by Regnery et al. [18]. We have also analysed a blood
sample from a patient following the same protocol. All tick
samples of clinical origin, and 33 of 38 from mammals, showed
Table 2. Results of the serological and PCR assays
R. conorii R. slovaca PCR from the skin
Case IgM IgG IgM IgG Skin biopsy B. burgdorferi R. slovaca
1 Negative Negative NP NP NP NP NP
2 IgM 1 ⁄ 32 Negative NP NP NP NP NP
3 Negative Negative NP NP NP NP NP
4 Negative Negative NP NP NP NP NP
5 Negative Negative Negative Negative NP NP NP
6 IgM 1 ⁄ 64 Negative NP NP NP NP NP
7 Negative Negative NP NP NP NP NP
8 IgM 1 ⁄ 16 IgG 1 ⁄ 32 IgM 1 ⁄ 16 IgG 1 ⁄ 32 NP NP NP
9 Negative Negative NP NP NP NP NP
10 IgM 1 ⁄ 128 IgG 1 ⁄ 128 NP NP NP NP NP
11 IgM 1 ⁄ 16 IgG 1 ⁄ 128 IgM 1 ⁄ 16 IgG 1 ⁄ 128 NP NP NP
12 IgM 1 ⁄ 32 IgG 1 ⁄ 128 NP NP NP NP NP
13 IgM 1 ⁄ 64 IgG 1 ⁄ 128 NP NP NP NP NP
14 Negative IgG 1 ⁄ 32 Negative Negative NP NP NP
15 IgM 1 ⁄ 16 IgG 1 ⁄ 64 IgM 1 ⁄ 16 IgG 1 ⁄ 64 NP NP NP
16a Negative Negative Negative Negative Performed Negative Negative
17 Negative Negative Negative Negative NP NP NP
18 Negative Negative Negative Negative NP NP NP
19 Negative Negative Negative Negative Performed Negative Negative
20 Negative Negative Negative Negative Performed Negative Negative
21 Negative Negative Negative Negative NP NP NP
22 Negative IgG 1 ⁄ 128 Negative Negative NP NP NP
NP, not performed.
aFor case 16, PCR from the tick was positive for Rickettsia spp.
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the presence of the ompA gene of Rickettsia spp. Five samples
(four from patients and one from a wild boar) were sequenced.
In two cases (one from a wild boar and one from a tick collected
from a patient), the amplicons were identical to the ompA gene
belonging to R. slovaca. In the remaining cases (one from blood
and three from ticks), the amplicons showed highest similarity
(98–97%) to Rickettsia sp. JL-02, Rickettsia sp. RpA4, Rickettsia
sp. DnS14 and Rickettsia sp. DnS28.
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